These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10073325)

  • 1. Hormonal effects on tirilazad clearance in women: assessment of the role of CYP3A.
    Fleishaker JC; Pearson LK; Pearson PG; Wienkers LC; Hopkins NK; Peters GR
    J Clin Pharmacol; 1999 Mar; 39(3):260-7. PubMed ID: 10073325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hormone replacement therapy on CYP3A activity.
    Gorski JC; Wang Z; Haehner-Daniels BD; Wrighton SA; Hall SD
    Clin Pharmacol Ther; 2000 Oct; 68(4):412-7. PubMed ID: 11061581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of tirilazad in human: 2. Effect of ketoconazole on tirilazad clearance and oral bioavailability.
    Fleishaker JC; Pearson PG; Wienkers LC; Pearson LK; Peters GR
    J Pharmacol Exp Ther; 1996 May; 277(2):991-8. PubMed ID: 8627582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotransformation of tirilazad in human: 1. Cytochrome P450 3A-mediated hydroxylation of tirilazad mesylate in human liver microsomes.
    Wienkers LC; Steenwyk RC; Sanders PE; Pearson PG
    J Pharmacol Exp Ther; 1996 May; 277(2):982-90. PubMed ID: 8627581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between St John's wort and an oral contraceptive.
    Hall SD; Wang Z; Huang SM; Hamman MA; Vasavada N; Adigun AQ; Hilligoss JK; Miller M; Gorski JC
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam.
    Kashuba AD; Bertino JS; Rocci ML; Kulawy RW; Beck DJ; Nafziger AN
    Clin Pharmacol Ther; 1998 Sep; 64(3):269-77. PubMed ID: 9757150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single plasma sampling to predict oral clearance of CYP3A probe midazolam.
    Zhu B; Ou-Yang DS; Cheng ZN; Huang SL; Zhou HH
    Acta Pharmacol Sin; 2001 Jul; 22(7):634-8. PubMed ID: 11749829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosis.
    Pearson LK; Fleishaker JC; Peters GR
    Eur J Clin Pharmacol; 1996; 50(4):299-304. PubMed ID: 8803523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age and gender on tirilazad pharmacokinetics in humans.
    Hulst LK; Fleishaker JC; Peters GR; Harry JD; Wright DM; Ward P
    Clin Pharmacol Ther; 1994 Apr; 55(4):378-84. PubMed ID: 8162663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tirilazad clearance by phenytoin.
    Fleishaker JC; Pearson LK; Peters GR
    Biopharm Drug Dispos; 1998 Mar; 19(2):91-6. PubMed ID: 9533108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies.
    Goh BC; Lee SC; Wang LZ; Fan L; Guo JY; Lamba J; Schuetz E; Lim R; Lim HL; Ong AB; Lee HS
    J Clin Oncol; 2002 Sep; 20(17):3683-90. PubMed ID: 12202670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tirilazad in healthy male subjects at doses above 6 mg/kg/day.
    Fleishaker JC; Peters GR
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):28-32. PubMed ID: 9021439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of tirilazad mesylate in male and female rats. Contribution of cytochrome P4502C11 and delta 4-5 alpha-reductase.
    Wienkers LC; Steenwyk RC; Mizsak SA; Pearson PG
    Drug Metab Dispos; 1995 Mar; 23(3):383-92. PubMed ID: 7628305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of tirilazad in human: 4. effect of finasteride on tirilazad clearance and reduced metabolite formation.
    Fleishaker JC; Pearson PG; Wienkers LC; Pearson LK; Moore TA; Peters GR
    J Pharmacol Exp Ther; 1998 Nov; 287(2):591-7. PubMed ID: 9808685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism.
    Paine MF; Khalighi M; Fisher JM; Shen DD; Kunze KL; Marsh CL; Perkins JD; Thummel KE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1552-62. PubMed ID: 9400033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CYP3A inhibition on vesnarinone metabolism in humans.
    Wandel C; Lang CC; Cowart DC; Girard AF; Bramer S; Flockhart DA; Wood AJ
    Clin Pharmacol Ther; 1998 May; 63(5):506-11. PubMed ID: 9630823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
    Chalasani N; Gorski JC; Patel NH; Hall SD; Galinsky RE
    Hepatology; 2001 Dec; 34(6):1103-8. PubMed ID: 11731998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of tirilazad: effects of weight, gender, concomitant phenytoin, and subarachnoid hemorrhage.
    Fleishaker JC; Fiedler-Kelly J; Grasela TH
    Pharm Res; 1999 Apr; 16(4):575-83. PubMed ID: 10227715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.